Last updated on February 2018

PTH - Preemptive Treatment for Herpesviridae


Brief description of study

The aim of this study is to show that a preemptive treatment by ganciclovir (for positive CMV viremia) or aciclovir (for positive HSV oro-pharyngeal PCR) is able to increase the number of ventilator-free days at Day 60.

Clinical Study Identifier: NCT02152358

Contact Investigators or Research Sites near you

Start Over

Laurent Papazian, MD, PhD

Assistance Publique - H pitaux de Marseille
Marseille, France
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.